ReMARk: Targeting rural HPV cancer prevention gaps
Official title: ReMARk: A multi-level strategy to address disparities in rural HPV-related cancer prevention
Funded at University of Florida · NIH-11554693 · Data updated 2026-11-12
A rural-focused initiative will map cancer risk in small neighborhoods to find where HPV prevention efforts like vaccines and screening are most needed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | September 22, 2022 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $99,930 |
| NIH project number | 3R01CA268014-04S1 |
| Project ID | NIH-11554693 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are residents of rural communities within the 23 Florida counties studied, especially those in high-burden census tracts.
✕Less likely to help
Individuals in areas with low burden or those not participating in prevention programs may see minimal direct benefit.
What this research studies
This project uses existing prevention data in 23 rural Florida counties to zoom in from county to neighborhood levels, identifying census tracts with the highest HPV-related cancer burden. Researchers will examine local factors that influence vaccine uptake and screening and test strategies to allocate prevention resources more effectively. The goal is to guide communities and health systems in prioritizing outreach and services to reduce preventable HPV-related cancers. The work builds on real-world data and aims to translate findings into practical actions for rural populations.
Why it matters
Potential benefit: If successful, communities could see more targeted prevention efforts, potentially lowering HPV-related cancer cases in high-need areas.
How similar studies have gone: Previous studies show that targeting high-burden neighborhoods can improve prevention uptake and reduce cancer risk.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Staras, Stephanie a S — University of Florida
- Study coordinator: Staras, Stephanie a S
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial pores and muscle loss in cancer cachexia
A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.
-
Photobiomodulation for jaw pain from TMD
A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.
-
How the brain controls swallowing and airway protection
A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.
-
Donor-driven 3D organoid platform to study pancreatic cancer drug response
A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.
-
RAAS inhibitors and pancreatic cancer risk in diverse adults
A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.
-
Pilot project exploring new cancer drugs for pancreatic cancer in African American patients
A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.